⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1228775 | 0.92 | TSHR (0.31) | — | |
| Bromide SCHEMBL218156 | 0.92 | TSHR (0.31) | — | |
| Water SCHEMBL486826 | 0.92 | TSHR (0.31) | — | |
| Hydrochloric Acid SCHEMBL21698 | 0.92 | TSHR (0.31) | — | |
| SCHEMBL9483756 | 0.92 | TSHR (0.31) | — | |
| SCHEMBL3115471 | 0.92 | TSHR (0.33) | — | |
| Iodide SCHEMBL1568039 | 0.92 | TSHR (0.31) | — | |
| Hydrochloric Acid SCHEMBL10456203 | 0.92 | TSHR (0.31) | — | |
| SCHEMBL22686936 | 0.92 | TSHR (0.31) | — | |
| Fluoride Ion SCHEMBL1538592 | 0.92 | TSHR (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8354557-B2 | Synthesis of deuterated morpholine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2013-01-15 | — | — | US | claimed |
| US-20100160247-A1 | Synthesis of deuterated morpholine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2010-06-24 | — | — | US | claimed |
| WO-2009154754-A2 | SYNTHESIS OF DEUTERATED MORPHOLINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2009-12-23 | — | — | WO | claimed |
| US-12384790-B2 | Pteridinone compounds and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250179026-A1 | Deuterium-Enriched 3,5-Dimethylpyrazolyl-3-propoxy-4-fluorobenzoic Acids for Treatment of Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) and Polyneuropathy (ATTR-PN), and Related Diseases | DHANOA DALJIT SINGH (US) | 2025-06-05 | — | — | US | disclosed |
| WO-2024206053-A2 | FLUOROALCOHOLS AS CO-SOLVENTS FOR CHEMICAL SYNTHESIS AND METHODS FOR PRODUCING THE SAME | UNIVERSITY OF MISSISSIPPI (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-113906020-B | Cyclic bradykinin B2 receptor antagonists | 法瓦里斯有限责任公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-112218865-B | Pteridinone compounds and uses thereof | 沃泰克斯药物股份有限公司 | 2024-03-12 | — | — | CN | disclosed |
| EP-3784669-B1 | PTERIDINONE COMPOUNDS AND USES THEREOF | VERTEX PHARMA (US) | 2023-10-25 | — | — | EP | disclosed |
| US-20230312587-A1 | PTERIDINONE COMPOUNDS AND USES THEREOF | VERTEX PHARMACEUTICALS INCORPORATED | 2023-10-05 | — | — | US | disclosed |
| US-11572364-B2 | Pteridinone compounds and uses thereof | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2023-02-07 | — | — | US | disclosed |
| EP-2358198-A1 | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2011-08-24 | — | — | EP | disclosed |
| WO-2011060363-A2 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110117214-A1 | CYCLOHEXYL UREA MODULATORS OF D2 RECEPTORS AND/OR D3 RECEPTORS | AUSPEX PHARMACEUTICALS, INC. (US) | 2011-05-19 | — | — | US | disclosed |
| US-20110028496-A1 | Deuterium-enriched pyrimidine compounds and derivatives | DHANOA DALJIT SINGH | 2011-02-03 | — | — | US | disclosed |
| WO-2010075090-A2 | SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20100160247-A1 | Synthesis of deuterated morpholine derivatives | CONCERT PHARMACEUTICALS, INC. (US) | 2010-06-24 | — | — | US | disclosed |
| US-20100152224-A1 | SCOPINE MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | US | disclosed |
| WO-2010047819-A1 | HYDROXYETHYLAMINO SULFONAMIDE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2009154754-A2 | SYNTHESIS OF DEUTERATED MORPHOLINE DERIVATIVES | CONCERT PHARMACEUTICALS, INC. (US) | 2009-12-23 | — | — | WO | disclosed |